{"title":"Covid-19疫苗的专利是基于公共研究","authors":"M. Florio","doi":"10.25518/ciriec.wp202103","DOIUrl":null,"url":null,"abstract":"The COVID-19 pandemic has forced us to reconsider the relationship between public and private research and development. The policy issue is whether, over the next 20 years, governments’ only negotiating position on biomedical technologies will be to sign one purchase contract after another and transfer value from tax payers to investors in pharmaceutical companies. Knowledge and technologies that are crucial to Covid-19 vaccine development and production were created with the contribution of governments. Patents filed by pharma companies do not protect the public interest arising from such earlier research. The paper offers a case study on the privatization of knowledge created in the first place by research and development in the public sector or supported by public funds and eventually being appropriated by pharmaceutical corporations.","PeriodicalId":228038,"journal":{"name":"CIRIEC Working papers","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Patents for Covid-19 vaccines are based on public research\",\"authors\":\"M. Florio\",\"doi\":\"10.25518/ciriec.wp202103\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The COVID-19 pandemic has forced us to reconsider the relationship between public and private research and development. The policy issue is whether, over the next 20 years, governments’ only negotiating position on biomedical technologies will be to sign one purchase contract after another and transfer value from tax payers to investors in pharmaceutical companies. Knowledge and technologies that are crucial to Covid-19 vaccine development and production were created with the contribution of governments. Patents filed by pharma companies do not protect the public interest arising from such earlier research. The paper offers a case study on the privatization of knowledge created in the first place by research and development in the public sector or supported by public funds and eventually being appropriated by pharmaceutical corporations.\",\"PeriodicalId\":228038,\"journal\":{\"name\":\"CIRIEC Working papers\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"CIRIEC Working papers\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.25518/ciriec.wp202103\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"CIRIEC Working papers","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25518/ciriec.wp202103","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Patents for Covid-19 vaccines are based on public research
The COVID-19 pandemic has forced us to reconsider the relationship between public and private research and development. The policy issue is whether, over the next 20 years, governments’ only negotiating position on biomedical technologies will be to sign one purchase contract after another and transfer value from tax payers to investors in pharmaceutical companies. Knowledge and technologies that are crucial to Covid-19 vaccine development and production were created with the contribution of governments. Patents filed by pharma companies do not protect the public interest arising from such earlier research. The paper offers a case study on the privatization of knowledge created in the first place by research and development in the public sector or supported by public funds and eventually being appropriated by pharmaceutical corporations.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
